Anna focuses on biotechnology, agriculture, and industrial investments. She takes an active role in supporting portfolio companies through business development, interim VP of Finance/CFO positions, or fundraising strategy.
Anna joined DCVC Bio at the fund’s formation in 2018 and has been an integral part of the team. Prior to DCVC Bio, Anna was at Monsanto Growth Ventures, where she covered agtech investments in crop health, supply chain, and digital agriculture. Anna also brings public market expertise from Moore Capital and SC Fundamental, where she served as a long-short equity Analyst. Anna started her career at a fast-growing M&A advisory firm, Centerview Partners, in their New York office. In her free time, Anna loves to hike, paint, and spend time with her husband and their cat.
Anna holds a bachelor’s degree in mathematics-economics with a minor in visual arts from Columbia University and an MBA from Harvard Business School (HBS). She has been featured in Forbes magazine and is a co-author of an HBS case.
